- FDA targets Lilly, Novartis, BMS and more in deluge of marketing letters Fierce Pharma
- FDA takes aim at Hims & Hers, weight loss drugs in new advertising blitz AP News
- Hims & Hers Stock: How It Found Itself in the FDA’s Crosshairs Barron’s
- Opinion | I Run the F.D.A. Pharma Ads Are Hurting Americans. The New York Times
- U.S. FDA sends drug advertising warning letters to Lilly, Novo, Hims Reuters
Source link